It is currently Thu Oct 30, 2014 9:09 pm

News News of General Discussion

Site map of General Discussion » Forum : General Discussion

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

SF1019

Does anyone know anything about SF1019? Apparently, Alan Osmond has used it for his MS, with success. It could be similar to Aimspro and does not have FDA approval. It may be a furphy but who knows?
Read more : SF1019 | Views : 21909 | Replies : 55


Understanding MS 102: My Doctor is Expressing Cytokines

Understanding MS 102: My Doctor is Expressing Cytokines: Code Cipher Training

This is part of my continuing effort to understand Multiple Sclerosis as best as I can. I’m documenting my efforts as I go because I figure there are a few more others like me who would like to try and understand this stuff the way I’m trying to. I’ve made hyperlinks in blue in hopes that this narrative may be more like a beginning ...
Read more : Understanding MS 102: My Doctor is Expressing Cytokines | Views : 3020 | Replies : 7


Progressive stage

The thing that still stuns me about this disease is the lack of treatments for the progressive phases - the really crap phases in my view, when disability starts ramping up. The is a question from the MS Society Canada and really illustrates how piss poor treatment options are.

Ian

http://www.msanswers.ca/QuestionView.aspx?L=2&QID=84
Read more : Progressive stage | Views : 1914 | Replies : 6


Bacterial Infections and CSF Research

Hi all

Given all the interest in infections here's another study from Ectrims 2006 that I'm also surprised no one has posted. :roll:
PCR for bacteria in multiple sclerosis cerebrospinal fluid
J.W. Lindsey, S. Patel (Houston, USA)

Objective: The objective of this study was to use a sensitive PCR method to test for the presence of seven different groups of bacteria in the cerebrospinal fluid (CSF) ...
Read more : Bacterial Infections and CSF Research | Views : 1382 | Replies : 2


Age and MS

Age Should Not Deter Multiple Sclerosis Diagnosis: Presented at ECTRIMS
By Bruce Sylvester

MADRID, SPAIN -- October 1, 2006 -- In a new study of patients diagnosed with multiple sclerosis (MS) after the age of 60, nearly half of relapsing patients with relapsing-remitting multiple sclerosis (RRMS) and patients with clinically isolated syndrome presented with signs of inflammation on magnetic resonance imaging (MRI).

This finding suggests that the disease course depends on the inflammatory component of ...
Read more : Age and MS | Views : 1197 | Replies : 3


Forgot the name of a website

Can anyone tell me the name of that website for pharmaceutical "professionals"? It's the one with all of the potty mouth newbie drug reps. I'm trying to find out who the Biogen rep for my area is.
Read more : Forgot the name of a website | Views : 1443 | Replies : 2


Disability, axonal degeneration

I have been reading a little and understanding a little on this axonal degeneration and disability connection. Gary has lots of disability and little brain lesions, so it "fits" his MS. A few years ago they did a spinal MRI and a DR noted in a known area of attacks spinal atrophy. Which basically is shrinkage? I read in Lyon's article on another post about all of this except they were talking about the brain ...
Read more : Disability, axonal degeneration | Views : 3288 | Replies : 20


Cyclophosphamide

This is a story of a couple of months ago, but is doing the rounds again. It's something cheery for a Monday.

Ian


MS treatment 'a miracle'

Rocky Point woman undergoes high-dose regimen at Stony Brook.
Linda Jacobellis had multiple sclerosis, a disease for which there is no cure, for 16 years. Now, she announces, "I no longer have MS." She ascribes her cure, in part, to "a miracle from my mother in heaven." ...
Read more : Cyclophosphamide | Views : 1940 | Replies : 6


Genes story

This looks an interesing genes story


http://news.bbc.co.uk/1/hi/health/5379250.stm
Read more : Genes story | Views : 1037 | Replies : 0


Betaferon and the BENEFIT study

Betaferon Demonstrates Robust Reduction in Risk of Developing Multiple Sclerosis Across All Subgroups of Benefit study



BERLIN, September 29, 2006-Schering AG (FSE: SCH, NYSE: SHR), Germany, announced today results from the subgroup analysis of the BENEFIT* study which showed that Betaferon® (interferon beta-1b) 250mcg treatment reduced the risk of developing clinically definite MS (CDMS) consistently across all subgroups regardless of age, gender, steroid treatment or symptoms at onset of disease.1 These data were part of ...
Read more : Betaferon and the BENEFIT study | Views : 831 | Replies : 0


 

Login  •  Register


Statistics

Total posts 221004 • Total topics 22913 • Total members 14472


Contact us | Terms of Service